Literature DB >> 97915

Determination of k/l immunoglobulin light chain ratios in CSF from patients with multiple sclerosis and other neurological diseases.

K Eickhoff, R Heipertz, J Wikström.   

Abstract

Using antisera against Bence-Jones protein, the concentration of light chains type k and l can be determined in CSF. The calculation of the ratio of type k to type I light chains in CSF represents a sensitive measure for the evaluation of immunological processes involving the CNS. Our results demonstrate that an increase k/l ratio is encountered in 48% of CSF specimen from multiple sclerosis (MS) patients, but also in 50% from patients with other inflammatory diseases involving the CNS, in contrast to only 18% from other neurological diseases. In none of the MS or inflammatory cases is the altered k/l ratio the only indicator of a CNS inflammation, most commonly it is accompanied by an overproportional CSF-IgG elevation (increased QG ratio), an increased cell count or both. For these reasons determination of CSF k/l ratios is helpful in the differentiation of MS and other neurological diseases, but not for the differentiation of other inflammatory CNS diseases from MS.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97915     DOI: 10.1111/j.1600-0404.1978.tb02842.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Isoelectric focusing and crossed immunoelectrofocusing of CSF immunoglobulins in MS.

Authors:  A Sidén
Journal:  J Neurol       Date:  1979-07-11       Impact factor: 4.849

2.  Determination of CSF proteins by a simple and rapid immunonephelometric method.

Authors:  K G Kjellin; L B Hallander
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

3.  Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern.

Authors:  David Zeman; Pavel Hradílek; Zdeněk Svagera; Eva Mojžíšková; Ivana Woznicová; Olga Zapletalová
Journal:  Fluids Barriers CNS       Date:  2012-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.